Dr Lalpath Lab reported lower than Bloomberg expected Q3 results. Company reported Q3 net profit Rs443mn (up 27% YoY) - Bloomberg expectation Rs486mn, other income Rs150mn vs Rs53mn, EBITDA Rs656mn (up 15.6% YoY), EBITDA margin up 88bps at 22.4% and income Rs2.93bn (up 11.3% YoY) - Expectation Rs3.02bn